Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants	Units counted
Overall Study	STARTED	PRO-157 BID (2 Times Per Day)	30	60
Overall Study	STARTED	PRO-157 TID (3 Times Per Day)	30	60
Overall Study	STARTED	PRO-157 QID (4 Times Per Day)	30	60
Overall Study	STARTED	Moxifloxacin (Vigamox®)	30	60
Overall Study	STARTED	Gatifloxacin (Zymar®)	30	60
Overall Study	COMPLETED	PRO-157 BID (2 Times Per Day)	27	54
Overall Study	COMPLETED	PRO-157 TID (3 Times Per Day)	19	38
Overall Study	COMPLETED	PRO-157 QID (4 Times Per Day)	24	48
Overall Study	COMPLETED	Moxifloxacin (Vigamox®)	21	42
Overall Study	COMPLETED	Gatifloxacin (Zymar®)	20	40
Overall Study	NOT COMPLETED	PRO-157 BID (2 Times Per Day)	3	6
Overall Study	NOT COMPLETED	PRO-157 TID (3 Times Per Day)	11	22
Overall Study	NOT COMPLETED	PRO-157 QID (4 Times Per Day)	6	12
Overall Study	NOT COMPLETED	Moxifloxacin (Vigamox®)	9	18
Overall Study	NOT COMPLETED	Gatifloxacin (Zymar®)	10	20

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02980523/flow